From: Serum microRNA signatures and metabolomics have high diagnostic value in gastric cancer
Variable | Patients (n = 80) | Control subjects (n = 82) | P value |
---|---|---|---|
Age (year) | 65.1 ± 10.5 | 34.8 ± 7.3 | < 0.001 |
Gender | 0.090 | ||
Male | 57 | 48 | |
Female | 23 | 34 | |
Tumor size (cm) | 4.27 ± 2.62 | ||
> 5 | 49 | ||
≥ 5 | 31 | ||
TNM stage | |||
I | 20 | ||
II | 18 | ||
III | 31 | ||
IV | 11 | ||
Histological grade | |||
I | 4 | ||
II | 14 | ||
II~III | 25 | ||
IV | 37 | ||
Lauren classification | |||
Diffuse | 25 | ||
Intestinal | 31 | ||
Mixed | 24 | ||
Tumor localization | |||
Cardia | 19 | ||
Corpus | 8 | ||
Antrum | 43 | ||
Whole | 10 |